Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

PURPOSE: Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of early mortality (EM). In a multicenter randomized comparison against oral chemotherapy, autotransplantation was associated with 24% E...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Clin Oncol
Main Authors: D'Souza, Anita, Dispenzieri, Angela, Wirk, Baldeep, Zhang, Mei-Jie, Huang, Jiaxing, Gertz, Morie A., Kyle, Robert A., Kumar, Shaji, Comenzo, Raymond L., Peter Gale, Robert, Lazarus, Hillard M., Savani, Bipin N., Cornell, Robert F., Weiss, Brendan M., Vogl, Dan T., Freytes, César O., Scott, Emma C., Landau, Heather J., Moreb, Jan S., Costa, Luciano J., Ramanathan, Muthalagu, Callander, Natalie S., Kamble, Rammurti T., Olsson, Richard F., Ganguly, Siddhartha, Nishihori, Taiga, Kindwall-Keller, Tamila L., Wood, William A., Mark, Tomer M., Hari, Parameswaran
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2015
נושאים:
ORIGINAL REPORTS
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737858/
https://ncbi.nlm.nih.gov/pubmed/26371138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.4015
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים